Myriad Genetics, Inc.
MYGN · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $824M | $838M | −1.6% |
| Operating income | −$387M | −$124M | −214% |
| Net income | −$366M | −$127M | −187% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 6, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $203M | $206M | −1.5% |
| Operating income | −$39.9M | −$23.3M | −71.2% |
| Net income | −$43.9M | −$27.4M | −60.2% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Myriad Genetics's revenue in FY2025?
- $824M in FY2025 (Fiscal year ended Dec 31, 2025), −1.6% vs $838M a year earlier, per its 10-K filed Feb 2026.
- Was Myriad Genetics profitable in FY2025?
- No: net income was −$366M and operating income −$387M in FY2025.
- What was Myriad Genetics's revenue in Q3 2026?
- $203M (−1.5% vs a year earlier), per its Form 10-Q filed Nov 6, 2026.